)
Asian shares declined Wednesday, echoing a fall on Wall Street, as political uncertainty took centrestage in Japan, making for cautious trading on the Tokyo Stock Exchange. Japan's benchmark Nikkei 225 shed 0.2 per cent in morning trading to 42,222.36. The fate of Japanese Prime Minister Shigeru Ishiba has been uncertain for weeks, with calls growing both for him to resign and to remain, after a recent election defeat and the rise of fringe parties have shaken public faith in the ruling Liberal Democratic Party. Confidence was rocked further by a recent comment from Ishiba's ally, Hiroshi Moriyama, who said he was stepping down as party secretary general. The political tremor is domestic, with Prime Minister Ishiba's key power broker signalling his resignation, shaking the foundations of the ruling party, said Stephen Innes, managing partner at SPI Asset Management. Australia's S&P/ASX200 slipped 1.1 per cent to 8,800.60. South Korea's Kospi edged up 0.3 per cent to 3,181.37. Hong
The industry, which employs over 800,000 skilled artisans, is heavily reliant on the US market, accounting for approximately 32 per cent of India's diamond exports
India's shift ends hopes of reducing China's global economic grip through unilateral trade cuts, as New Delhi, once leading that push, is now forced to reverse course
Trump told reporters that the US would appeal to the high court for relief as soon as Wednesday because "it would be a devastation for our country" if the appeals court ruling was left in place
Trump maintained that India imposed duties of up to 100 per cent on various goods, which discouraged US firms from exporting there
Stock market close highlights, September 2: The BSE Sensex dropped 752.64 pts from its intraday high of 80,761.14 to touch a low of 80,008.50, before settling 206.61 pts, or 0.26% lower at 80,157.88.
India's pharmaceutical industry is currently exempt from U.S. President Donald Trump's tariffs of up to 50% but the sector has been on edge due to the uncertainty surrounding the situation
India faces a diplomatic rethink as Trump imposes tariffs and China reaches out, but history reminds New Delhi not to trust either blindly
In a veiled rebuttal to the 'dead economy' jibe, Prime Minister Narendra Modi on Tuesday said the Indian economy grew 7.8 per cent in the first quarter, surpassing all expectations despite global uncertainties and challenges driven by economic self-interest. Speaking at the Semicon India 2025 conference here, he said GDP growth in April-June was better than 'every expectation, hope and estimate'. Indian economic performance came amidst global uncertainties and "aarthik swarth se paida hue chunautiya hai" (challenges stemming from economic self-interest), he said. "Once again, India has outperformed every expectation, every estimate, and every forecast," Modi said. While economies around the world are facing concerns and challenges driven by economic self-interest, India has achieved a growth rate of 7.8 per cent. Modi emphasized that this growth is visible across all sectors -- manufacturing, services, agriculture, and construction -- with enthusiasm evident everywhere, and added
Chinese leader Xi Jinping welcomed Russian President Vladimir Putin as an old friend as the two began a series of meetings Tuesday at a time when their countries face both overlapping and differing challenges from the United States. Relations between China and Russia have deepened in recent years, particularly after the Russian invasion of Ukraine in early 2022. Putin addressed Xi as dear friend and said that Moscow's ties with Beijing are at an unprecedentedly high level. Following their formal talks, they planned to have another meeting over tea with some of their top aides. The talks come the day after both attended a summit of the Shanghai Cooperation Organisation in the nearby Chinese city of Tianjin, and the day before a grand Chinese military parade in Beijing to mark the 80th anniversary of the end of World War II. The Soviet Union was neutral for much of the war in Asia, but provided assistance to China in earlier fighting against invading Japanese forces in the 1930s. It
Ex-Biden adviser Jake Sullivan accused Trump of undermining US-India ties to favour Pakistan for family business, warning of global trust erosion
US Treasury Secretary warns of fresh tariffs, calls SCO 'performative'; Trump says India's high duties block US firms while it buys oil and arms from Russia
Emkay Global remains constructive on a consumption revival cascading from multiple fiscal and monetary stimuli
India's consumption story remains the most reliable theme for the next decade, says Inderbir Singh Jolly, chief executive officer at PL Wealth Management in an exclusive interview
Bank stocks extended losses as Nifty Bank index slipped 7% from its July peak. Analysts flag US tariff risks may hit HDFC Bank, IndusInd Bankm City Union Bank, Federal Bank
India-US trade deal: Trump said that India does a tremendous amount of business with the US, while the US does very little with India
Stock market close highlights on Monday, September 1, 2025: the BSE Sensex settled 554.84pts or 0.70% higher at 80,364.49 levels, while Nifty50 ended 198.20 pts or 0.81% higher at 24,625.05 levels.
President Donald Trump has plastered tariffs on products from almost every country on earth. He's targeted specific imports, including autos, steel and aluminium. But he isn't done yet. Trump has promised to impose hefty import taxes on pharmaceuticals, a category of products he's largely spared in his trade war. For decades, in fact, imported medicine has mostly been allowed to enter the United States duty-free. That's starting to change. US and European leaders recently detailed a trade deal that includes a 15 per cent tariff rate on some European goods brought into the United States, including pharmaceuticals. Trump is threatening duties of 200 per cent more on drugs made elsewhere. Shock and awe' is how Maytee Pereira of the tax and consulting firm PwC describes Trump's plans for drugmakers. This is an industry that's going from zero (tariffs) to the potential of 200 per cent.' Trump has promised Americans he'll lower their drug costs. But imposing stiff pharmaceutical tariffs
The post comes amid strained relations between India and the US after the Donald Trump-led administration imposed 50 per cent tariffs on Indian imports
India defended its Russian oil imports, saying it followed international rules and helped keep global prices stable, rejecting US claims that it fueled the Russian war effort